These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 16443270)

  • 1. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery.
    Kim DH; Martin DC
    Biomaterials; 2006 May; 27(15):3031-7. PubMed ID: 16443270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings.
    Norton LW; Tegnell E; Toporek SS; Reichert WM
    Biomaterials; 2005 Jun; 26(16):3285-97. PubMed ID: 15603824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A facile method to prepare heparin-functionalized nanoparticles for controlled release of growth factors.
    Chung YI; Tae G; Hong Yuk S
    Biomaterials; 2006 Apr; 27(12):2621-6. PubMed ID: 16360204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying.
    Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J
    Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of anti-restenosis drugs from poly(ethylene oxide)-poly(DL-lactic-co-glycolic acid) nanoparticles.
    Zweers ML; Engbers GH; Grijpma DW; Feijen J
    J Control Release; 2006 Sep; 114(3):317-24. PubMed ID: 16884807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
    Budhian A; Siegel SJ; Winey KI
    Int J Pharm; 2007 May; 336(2):367-75. PubMed ID: 17207944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality.
    McCarron PA; Marouf WM; Donnelly RF; Scott C
    J Biomed Mater Res A; 2008 Dec; 87(4):873-84. PubMed ID: 18228271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
    Dong Y; Feng SS
    Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local release of dexamethasone from polymer millirods effectively prevents fibrosis after radiofrequency ablation.
    Blanco E; Weinberg BD; Stowe NT; Anderson JM; Gao J
    J Biomed Mater Res A; 2006 Jan; 76(1):174-82. PubMed ID: 16265662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diphtheria toxoid loaded poly-(epsilon-caprolactone) nanoparticles as mucosal vaccine delivery systems.
    Singh J; Pandit S; Bramwell VW; Alpar HO
    Methods; 2006 Feb; 38(2):96-105. PubMed ID: 16442811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vectorization of copper complexes via biocompatible and biodegradable PLGA nanoparticles.
    Courant T; Roullin VG; Cadiou C; Delavoie F; Molinari M; Andry MC; Gafa V; Chuburu F
    Nanotechnology; 2010 Apr; 21(16):165101. PubMed ID: 20348590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel technique for loading of paclitaxel-PLGA nanoparticles onto ePTFE vascular grafts.
    Lim HJ; Nam HY; Lee BH; Kim DJ; Ko JY; Park JS
    Biotechnol Prog; 2007; 23(3):693-7. PubMed ID: 17465527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors.
    Parajó Y; d'Angelo I; Horváth A; Vantus T; György K; Welle A; Garcia-Fuentes M; Alonso MJ
    Eur J Pharm Sci; 2010 Dec; 41(5):644-9. PubMed ID: 20869438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles.
    Esmaeili F; Hosseini-Nasr M; Rad-Malekshahi M; Samadi N; Atyabi F; Dinarvand R
    Nanomedicine; 2007 Jun; 3(2):161-7. PubMed ID: 17468055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encapsulation of dexamethasone into biodegradable polymeric nanoparticles.
    Gómez-Gaete C; Tsapis N; Besnard M; Bochot A; Fattal E
    Int J Pharm; 2007 Mar; 331(2):153-9. PubMed ID: 17157461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres.
    Zolnik BS; Burgess DJ
    J Control Release; 2008 Apr; 127(2):137-45. PubMed ID: 18282629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
    Choi SH; Park TG
    Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLGA microparticle-embedded thermosensitive hydrogels for sustained release of hydrophobic drugs.
    Joung YK; Choi JH; Park KM; Park KD
    Biomed Mater; 2007 Dec; 2(4):269-73. PubMed ID: 18458485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.